Knockdown of L calcium channel subtypes: differential effects in neuropathic pain

Pascal Fossat1, Eric Dobremez, Rabia Bouali-Benazzouz

  • 1INSERM U862, Magendie Neurocenter, Pathophysiology of spinal networks group, 33077 Bordeaux Cedex, France.

Insights

Chronic pain involves gene regulation, with L-type calcium channels (LTCs) crucial for this process. Targeting Ca(V)1.2 channels in the spinal cord reversed pain sensitization in neuropathy models.

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Pain Research

Background:

  • Chronic pain maintenance requires gene expression regulation, influenced by calcium influx.
  • Neuronal L-type voltage-gated calcium channels (LTCs) are vital for excitation-transcription coupling.
  • The specific role of LTC subtypes in chronic pain states is not well understood.

Purpose of the Study:

  • To investigate the involvement of LTC subtypes Ca(V)1.2 and Ca(V)1.3 in long-term pain sensitization.
  • To elucidate the role of Ca(V)1.2 in the gene expression changes associated with neuropathic pain.

Main Methods:

  • Utilized a peptide nucleic acid (PNA) antisense strategy to target Ca(V)1.2 and Ca(V)1.3 in a rat neuropathy model.
  • Administered anti-Ca(V)1.2 small interfering RNAs (siRNAs) intrathecally.
  • Assessed mechanical hypersensitivity, neuronal excitability, and gene/protein expression (Ca(V)1.2, CREB, COX-2).

Main Results:

  • Specific knockdown of Ca(V)1.2 in the spinal dorsal horn reversed mechanical hypersensitivity and neuronal hyperexcitability.
  • Neuropathic rats showed increased Ca(V)1.2 mRNA and protein levels.
  • Ca(V)1.2 activation mediated CREB phosphorylation and enhanced transcription of the CREB/CRE-dependent gene COX-2.

Conclusions:

  • L-type calcium channels, particularly Ca(V)1.2, play a significant role in spinal pain processing.
  • The maintenance of chronic neuropathic pain is dependent on Ca(V)1.2 channels in the spinal dorsal horn.

Related Concept Videos

Antihypertensive Drugs: Action of Calcium Channel Blockers01:18

Antihypertensive Drugs: Action of Calcium Channel Blockers

Calcium ions are essential to contract smooth muscle cells in blood vessels. They enter these cells through voltage-dependent calcium channels, specifically L-type calcium channels in the cell membrane. These L-type calcium channels are integral to the excitation-contraction coupling process in smooth muscle. When a stimulus is received by smooth muscle cells, their membrane depolarizes. This alteration in membrane potential instigates the opening of L-type calcium channels. As a result,...
Local Anesthetics: Differential Sensitivity of Nerve Fibers01:24

Local Anesthetics: Differential Sensitivity of Nerve Fibers

Local anesthetics (LAs) block the sodium channels of nerve trunks, sensory nerve endings, and neuromuscular junctions. Although LAs can block all kinds of nerves, the sensitivity of nerve fibers differs according to nerve types and structures. LAs are known to block myelinated fibers faster than unmyelinated ones. Also, they block pain or sensory neurons at low concentrations without affecting the motor neurons involved in muscle contractions. This helps relieve labor pain without affecting the...
Ligand-Gated Ion Channel Receptor: Gating Mechanism01:30

Ligand-Gated Ion Channel Receptor: Gating Mechanism

Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
Local Anesthetics: Mechanism of Action01:23

Local Anesthetics: Mechanism of Action

Local anesthetics (LAs) block sensory and motor impulses by inhibiting the sodium channels on the nerve cell membranes. This induces temporary loss of sensation, relieving pain in a specific body area.
Local anesthetics are amphiphilic molecules consisting of a hydrophobic aromatic part linked to a hydrophilic group by an ester or amide linkage. They are weak bases and are usually available as salts, which increases their solubility and stability. Once administered, LAs exist in the body either...
Antianginal Drugs: Calcium Channel Blockers and Ranolazine01:25

Antianginal Drugs: Calcium Channel Blockers and Ranolazine

Angina pectoris, a primary symptom of ischemic heart disease, requires careful pharmacological interventions. In this context, calcium channel blockers (CCBs) and ranolazine have emerged as crucial pharmacotherapeutic agents, providing deep insights into the complexities of angina management.
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers01:20

Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers

Class IV antiarrhythmic drugs, such as verapamil and diltiazem, block calcium channels. They primarily affect the heart, slowing the conduction in calcium-dependent tissues like the SA and AV nodes. These drugs manage reentrant supraventricular tachycardia (SVT) and reduce ventricular rate in atrial flutter/fibrillation.
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...